MENU
CLRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cellectar Biosciences (CLRB) Ownership - Who owns Cellectar Biosciences?
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
20
Web
https://www.cellectar.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.21M
P/E Ratio
N/A
Total Cash
23.29M
Projected Growth
N/A
Total Debt
494K
Revenue
N/A
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash/Share
0.51
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CLRB
Capitalization
12.2M
P/E Ratio
N/A
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash
23.3M
Total Cash/Share
0.51
Total Debt
494K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
13.8M
P/B Ratio
0.88
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
461
Current Ratio
2.58
Current Revenue Per Employee
694.42
Dividends Per Share - Security
N/A
EBITDA
-51.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-237.45
Shares Held By Institutions
4.1M
Shares Outstanding - Current
46.1M
Total Liabilities
11.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-1.940
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
20
Web
https://www.cellectar.com